|
G |
Ahr |
aryl hydrocarbon receptor |
increases expression |
ISO |
Tryptophan results in increased expression of AHR mRNA |
CTD |
PMID:32781018 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions decreases abundance |
ISO |
PF-06840003 inhibits the reaction [APP protein mutant form results in decreased abundance of Tryptophan] |
CTD |
PMID:39172838 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression |
ISO |
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[Tryptophan co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1A1 mRNA]; [Tryptophan co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1A1 mRNA Tryptophan results in increased expression of CYP1A1 mRNA |
CTD |
PMID:32781018 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions increases expression |
ISO |
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [[Tryptophan co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1B1 mRNA]; [Tryptophan co-treated with [Medroxyprogesterone Acetate co-treated with Cyclic AMP]] results in increased expression of CYP1B1 mRNA Tryptophan results in increased expression of CYP1B1 mRNA |
CTD |
PMID:32781018 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
increases expression increases abundance |
ISO |
Tryptophan results in increased expression of IDO1 protein IDO1 gene mutant form results in increased abundance of Tryptophan |
CTD |
PMID:32781018 PMID:32871117 |
|
NCBI chr16:67,430,654...67,442,726
Ensembl chr16:67,430,578...67,442,730
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
IFNG protein promotes the reaction [Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]]; IFNG protein promotes the reaction [Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA]] |
CTD |
PMID:32781018 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
increases expression multiple interactions |
ISO |
Tryptophan results in increased expression of IGFBP1 mRNA 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]]; IFNG protein promotes the reaction [Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA]]; Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of IGFBP1 mRNA] |
CTD |
PMID:32781018 |
|
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
|
|
G |
Mapt |
microtubule-associated protein tau |
multiple interactions |
ISO |
[amyloid beta-protein (1-42) binds to MAPT protein] which results in decreased abundance of Tryptophan [amyloid beta-protein (1-42) binds to MAPT protein] which results in decreased abundance of Tryptophan; PF-06840003 inhibits the reaction [[amyloid beta-protein (1-42) binds to MAPT protein] which results in decreased abundance of Tryptophan] |
CTD |
PMID:39172838 |
|
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
|
|
G |
Prl |
prolactin |
multiple interactions increases expression |
ISO |
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA]]; IFNG protein promotes the reaction [Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA]]; Tryptophan promotes the reaction [[Medroxyprogesterone Acetate co-treated with Cyclic AMP] results in increased expression of PRL mRNA] Tryptophan results in increased expression of PRL mRNA |
CTD |
PMID:32781018 |
|
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
increases expression |
ISO |
Tryptophan results in increased expression of SLC7A5 mRNA |
CTD |
PMID:32781018 |
|
NCBI chr19:49,935,220...49,963,823
Ensembl chr19:49,935,220...49,963,823
|
|
G |
Tdo2 |
tryptophan 2,3-dioxygenase |
increases abundance |
ISO |
TDO2 gene mutant form results in increased abundance of Tryptophan |
CTD |
PMID:32871117 |
|
NCBI chr 2:167,269,581...167,287,511
Ensembl chr 2:167,269,579...167,287,511
|
|
G |
Tph1 |
tryptophan hydroxylase 1 |
multiple interactions |
EXP |
[TPH1 protein results in increased hydroxylation of Tryptophan] which results in increased chemical synthesis of 5-Hydroxytryptophan |
CTD |
PMID:32243540 |
|
NCBI chr 1:97,157,375...97,178,415
Ensembl chr 1:97,157,409...97,178,344
|
|
|
G |
Il13 |
interleukin 13 |
multiple interactions |
EXP |
ilomastat inhibits the reaction [Mustard Gas results in increased expression of IL13 protein] |
CTD |
PMID:18852015 |
|
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
multiple interactions |
EXP |
ilomastat affects the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MMP1 protein]; ilomastat inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of MMP1 mRNA] |
CTD |
PMID:18837084 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
multiple interactions |
EXP |
ilomastat affects the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TIMP1 mRNA]; ilomastat affects the reaction [Trinitrobenzenesulfonic Acid results in increased expression of TIMP1 protein] |
CTD |
PMID:18837084 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
EXP |
N-acetyltryptophan inhibits the reaction [Aluminum Chloride results in decreased activity of ACHE protein] |
CTD |
PMID:29185389 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Casp2 |
caspase 2 |
multiple interactions |
ISO |
N-acetyltryptophan inhibits the reaction [Cobalt-60 results in increased activity of CASP2 protein] |
CTD |
PMID:37702290 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
N-acetyltryptophan inhibits the reaction [Cobalt-60 results in increased activity of CASP3 protein] |
CTD |
PMID:37702290 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
N-acetyltryptophan inhibits the reaction [Cobalt-60 results in increased activity of CASP9 protein] |
CTD |
PMID:37702290 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions |
ISO |
N-acetyltryptophan inhibits the reaction [Cobalt-60 results in decreased activity of CAT protein] |
CTD |
PMID:37702290 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Xdh |
xanthine dehydrogenase |
multiple interactions |
ISO |
N-acetyltryptophan inhibits the reaction [Cobalt-60 results in increased activity of XDH protein] |
CTD |
PMID:37702290 |
|
NCBI chr 6:21,530,463...21,592,172
Ensembl chr 6:21,530,113...21,592,268
|
|
|
G |
Casp2 |
caspase 2 |
increases activity |
ISO |
violacein results in increased activity of CASP2 protein |
CTD |
PMID:20416285 |
|
NCBI chr 4:71,149,632...71,167,388
Ensembl chr 4:71,149,669...71,167,379
|
|
G |
Casp3 |
caspase 3 |
increases activity |
ISO |
violacein results in increased activity of CASP3 protein |
CTD |
PMID:20416285 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
violacein results in increased activity of CASP9 protein |
CTD |
PMID:20416285 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|